Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

Purinergic Signalling, published by Springer, is a pivotal academic journal dedicated to the exploration of purinergic signaling pathways and their implications in various biological processes. Since its inception in 2004, the journal has made significant contributions to the fields of Cell Biology, Cellular and Molecular Neuroscience, and Molecular Biology, consistently ranking in the Q3 category in recent assessments. With a strong focus on the molecular mechanisms of purines and their roles in physiology and pathology, Purinergic Signalling serves as an essential resource for researchers and professionals seeking to understand the complexity of cellular communication. Although it does not offer open access, the journal ensures a broad dissemination of high-quality research findings, making it a vital tool for academic advancement in the fields of neuroscience and molecular biology. Its commitment to scholarly excellence is reflected in its Scopus rankings, where it is competitively positioned within its categories. As we approach its 20th anniversary in 2024, Purinergic Signalling continues to inspire and inform cutting-edge research in the dynamic landscape of life sciences.

DEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.

TRAFFIC is a distinguished academic journal published by Wiley, serving as a vital resource in the fields of Biochemistry, Cell Biology, Genetics, Molecular Biology, and Structural Biology. With an impressive growth trajectory since its inception in 2000, the journal has consistently maintained a Q1 category ranking in the latest 2023 evaluations, placing it amongst the top-tier publications in its fields. TRAFFIC is based in Denmark and has become a cornerstone for researchers and professionals seeking to explore the intricate dynamics of cellular transport and its implications across biological processes. Despite not being an open-access journal, TRAFFIC offers comprehensive access options, ensuring vital contributions to the scientific community are readily available. With a proven track record and substantial impact, as evidenced by its Scopus rankings—such as rank #11 in Structural Biology—TRAFFIC continues to be an essential platform for disseminating influential research and fostering academic discourse.

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

CELL CALCIUM is a premier journal published by ELSEVIER SCI LTD, focusing on the critical role of calcium in cellular processes, making it an essential read for researchers and professionals in the fields of Cell Biology, Molecular Biology, and Physiology. Having been in publication since 1980, this journal is well-regarded, holding a Q2 ranking in Cell Biology and Molecular Biology, as well as a prestigious Q1 status in Physiology for 2023. With an impressive Scopus ranking that places it in the top 20% of journals in its categories, CELL CALCIUM aims to disseminate original research articles that advance the understanding of calcium signaling mechanisms and their implications in health and disease. Although not available via open access, its insights are critical for advancing knowledge and fostering collaboration within the scientific community. The journal is located in the United Kingdom, with its editorial excellence helping to promote high-impact research that continues to influence both academia and industry.

Welcome to the JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, a premier platform for the dissemination of cutting-edge research in the fields of anatomy and histology. Published by SAGE PUBLICATIONS LTD, this esteemed journal has been a cornerstone of academic inquiry since its inception in 1953 and continues to play a vital role in advancing our understanding of cellular structure and function. With an impressive Impact Factor reflected in its rank as Q1 in both Anatomy and Histology categories, the journal ranks #5 out of 48 in Medicine Anatomy and #17 out of 62 in Medicine Histology, making it an essential resource for researchers and professionals alike. The journal provides a rigorous peer-review process and encourages submissions that enhance the scientific community's knowledge. As a vital resource for students, professionals, and researchers focusing on histochemical methodologies, the JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY offers insights into the latest advancements and critical debates within this dynamic discipline.

Autophagy is a premier peer-reviewed journal published by Taylor & Francis, Inc. in the United States, focusing on advances in the fields of Cell Biology and Molecular Biology. With an impressive impact factor reflected in its Q1 ranking in both categories, Autophagy stands as a vital resource for researchers and professionals dedicated to understanding the intricate mechanisms of cellular degradation and recycling. The journal has been a cornerstone of scientific communication since its inception in 2005, continuing to flourish through 2024, fostering collaboration and innovation in the study of autophagic processes. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and its commitment to publishing high-quality, impactful research. By bridging fundamental research with clinical applications, Autophagy plays a crucial role in advancing our understanding of various diseases, making it an essential tool for scholars and practitioners in the biomedical field.

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, an esteemed journal published by VIA MEDICA, serves as a vital platform for researchers and professionals in the fields of histology, pathology, and cytobiology. With an ISSN of 0239-8508 and E-ISSN of 1897-5631, this Open Access journal has been disseminating significant findings since 1984, offering free access to a broad audience of scientists and academics. Based in Poland, this journal focuses on critical advancements in the study of cellular structures and functions, contributing substantially to the understanding of various diseases and biological processes. The journal currently holds a respectable impact factor, ranking in the Q3 category for Histology and miscellaneous Medicine, and Q2 for Pathology and Forensic Medicine as per the 2023 metrics. With its commitment to quality research and an inclusive publishing approach, FOLIA HISTOCHEMICA ET CYTOBIOLOGICA is poised to continue influencing its fields significantly through 2024 and beyond.